Extra geriatric and pharmacy support for older adults on oral cancer pills
Treatments studied
Part of Cancer, Digestive system, Kidney & urinary, Lungs & breathing, Skin, Women’s health & pregnancy clinical trials.
This study looks at whether adding extra support from a geriatric team and a pharmacist can help older patients (70+) take their oral cancer pills safely and effectively. You may be able to join if you are starting one of the listed oral therapies for your cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 70 years old or older.
- You have a solid tumor cancer that is locally advanced or has spread (breast, lung, prostate, colon, kidney, sarcoma, or GIST).
- You are about to start one of the listed oral treatments (such as abemaciclib, osimertinib, abiraterone, capecitabine, or similar).
- You have not been treated with that same oral therapy before, and you have not had specialized oncogeriatric care in the past 12 months.
- You are able to take oral medication and follow the study plan, and you can give informed consent.
- If you are female and could become pregnant, you must have a negative pregnancy test and agree to use contraception; if you are male and sexually active, you must agree to use a condom.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests approved cancer drugs in people aged 70 and older with non-small-cell lung cancer who haven't had systemic treatment before. The goal is to see how well these drugs work in this older population.
This study tests different treatments tailored to your cancer's biology. It aims to find which therapy might work best for you, potentially improving outcomes. You'd receive one of the study drugs, with close monitoring and support.
This study tests a set of practical support steps to help people with advanced cancer take their oral (by mouth) treatment medicines correctly. It may help improve adherence and reduce missed doses or appointments.
This study looks at whether adding special geriatric (older-adult) care to standard cancer treatment helps older patients manage their health better. The goal is to improve quality of life and reduce treatment complications.
This trial is testing whether adjusting the dose of a targeted therapy (CDK 4/6 inhibitor) based on a geriatric assessment can be as effective and safer for people aged 70 and older with advanced hormone receptor-positive, HER2-negative breast cancer. It aims to find the best dose to balance benefits and side effects.
This study is for older adults (65+) with solid tumors who are getting treatment to try to cure their cancer. It adds extra supportive care from a team that helps with the unique needs of frail older adults, to improve quality of life and treatment experience.
Hear when a new Elderly trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.